Alina Basnet

Assistant Professor of Medicine,
Fellowship Program Director,
GU medical oncologist,
SUNY Upstate Medical University

[Ghanshyam Ghelani @drghelani]

Comparative survival after Neoadjuvant vs Adjuvant systemic therapy in resectable stage II and stage III non-small cell lung cancer: A retrospective study using National Cancer Database.

[Alina Basnet @basneta16]

Signed!
https://t.co/XwkvOG3lvl via @Change

[Alina Basnet @basneta16]

@MarounBouZerdan @DeptVetAffairs @UpstateIM_Res @UpstateNews @upstate_DOM @NewYorkACP for a very deserving senior indeed!!

[channel✨💖 @harlee_luv008]

Cisplatin based chemotherapy + Nivolumab improves outcomes in metastatic urothelial cancer. https://t.co/LiF9jQmcKj @UroDocAsh @Uromigos @neerajaiims @DrYukselUrun @OncoAlert @TischCancer @montypal

[Laurence Albiges @AlbigesL]

Pleased to share @TheLancetOncol LENVA-PEMBRO across RCC variant histologies: papillary RCC, unclRCC and chromophobe RCC … interim @myESMO #ESMO22 and final @ChungHanLee3 @ASCO #ASCO23

full text: https://t.co/QioxQEiKho
Thanks to all who change
rareRCC pts Tx!

[Toni Choueiri, MD @DrChoueiri]

Important study to the #GU field!

Congrats @DrRosenbergMSK @MSKCancerCenter and team! cc; @JCO_ASCO @OncoAlert

[Sumanta K. Pal, MD, FASCO @montypal]

Friday thoughts:

Dear fellows & junior faculty,

Later in your career, the abstract section of your CV will be lengthy but people will gloss over it. Presenting abstracts is fun & an important part of academic development (via networking, honing presentation skills, etc.), but the papers are what ultimately count (on the job search & for promotion). Be sure that when you write an abstract, construction of the paper is underway. Having "hot of the press" data you've just presented at a meeting fed into a manuscript also appeals to editors/reviewers.

@DrChoueiri @neerajaiims @PGrivasMDPhD @TiansterZhang @WilliamDale_MD @stacywgray @DrRaviSalgia @ShikhaJainMD @NarjustFlorezMD

[Sumanta K. Pal, MD, FASCO @montypal]

At #ASCO23, @neerajaiims delivers a masterclass on how to weave (1) state-of-the-art clinical evidence with (2) real-world application of data with (3) limitations based on health disparities with (4) practical interventions to remedy them with (5) advocacy solutions. This talk focuses on #ProstateCancer but I encourage all @ASCO young investigators to review it. Also love the way he pays homage to the village of researchers (@CaPsurvivorship @AarmstrongDuke @lynn_schuchter @jrgralow @fizazikarim @PBarataMD @umangtalking @EAntonarakis @AlanBryce9 @scserendipity1) who are working towards making a change on all of the above. 👏👏 👏One of the best educational talks I have ever seen & I have seen many.

[Maroun Bou Zerdan, MD @MarounBouZerdan]

Last but not least, a 🗣️ shoutout to my amazing mentors who have been steadily guiding me through my scholarly 📚🔎 work @UpstateIM_Res:
@basneta16 (the 🔝boss ) and Dr. Jeffrey Ross from @FoundationATCG .
Fueling ⛽️ my desire in #KCSM and #raretumors

[Alina Basnet @basneta16]

@MarounBouZerdan @UpstateIM_Res @FoundationATCG So proud of you, Maroun 👏 . You are one excellent mentee that I have the privilege to work with. Thank you, Dr. Ross, for your support!!

[Santhosh Ambika @RenoHemonc]

@neerajaiims @ASCO Better to go with Cabazi if SUV <10

[Sumanta K. Pal, MD, FASCO @montypal]

Brilliant citation @marklewismd - appreciate the share. Completely agree that outpt and inpt oncology rotations are markedly different, with the former often being far more inspiring. Folks be sure to check out the @ASCO @JCO_ASCO link that Mark posted:

[Neeraj Agarwal, MD, FASCO @neerajaiims]

Breaking news from #AUA23 @AmerUrological : @siadaneshmand presents 1st results from SunRISE-1 trial 👉TAR-200 (local gemcitabine delivery system in bladder) in BCG refractory high-risk non-muscle invasive #bladdercancer 👉 amazing ~73% complete response 👇@OncoAlert @urotoday

[Shilpa Gupta @shilpaonc]

@neerajaiims @CellCellPress @fredhutch @SujataJanaPhD @HsiehLab @PGrivasMDPhD @montypal @DrChoueiri @DrYukselUrun @apolo_andrea @AndreaNecchi @UroDocAsh @TomFlaigMD @tompowles1 @brian_rini Congrats to @SujataJanaPhD and team on this stellar work!!

[Dr. Bishoy M. Faltas @FaltasLab]

Congratulations to my colleague @DrJonesNauseef on this important work #AACR2023

[Dr. Shruti Naik @DrShrutiNaik]

I can attest to experiencing this kind of bullying. Several times I’ve been asked how I’ve achieved career milestones. How did you get that grant? Paper? Talk?….. and then insinuate (or outright say) it’s because of dei kickbacks or my famous mentors

[Toni Choueiri, MD @DrChoueiri]

“Your living is determined not so much by what life brings to you as by the attitude you bring to life; not so much by what happens to you as by the way your mind looks at what happens”—Khalil Gibran, 19th Century.

[Toni Choueiri, MD @DrChoueiri]

1/ Excited to share with you our most recent study in @TheLancetOncol assessing the combination of belzutifan + cabozantinib in patients with advanced #RCC previously treated with immunotherapy #IO @DanaFarber @OncoAlert

https://t.co/4o2OHXlNya

Summary in the thread below 🧵

[Alina Basnet @basneta16]

https://t.co/rI0Ice02Ew